Lv4
418 积分 2024-02-02 加入
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2小时前
待确认
[Recommendations for the diagnosis and treatment of rheumatic diseases-related hemophagocytic syndrome in China]
9小时前
已完结
CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients
4天前
已完结
Classification and definition of major flares in SLE clinical trials
2个月前
已完结
Current challenges and emerging opportunities of CAR-T cell therapies
4个月前
已完结
Cancer-fighting immune cells could soon be engineered inside our bodies
4个月前
已完结
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
5个月前
已完结
B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis
5个月前
已完结
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analysis of participants in the BLISS-LN and open label extension study belonging to a single center
5个月前
已完结
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy
5个月前
已完结
皖公网安备34019202002308
